Endovascular Engineering

Menlo Park, CA · Founded 2019 · Privately Held (backing)

Developer of a minimally invasive thrombectomy system designed to remove pulmonary embolisms efficiently while minimizing patient risk. Endovascular Engineering is based in Menlo Park, CA and was founded in 2019. Its last reported valuation was $215 million in Apr 2026. It has raised $141 million.

Last reported valuation
$215.0M
Oct 2026
Priced at
—
Total raised
$141.0M
Last round
—

Who backs Endovascular Engineering?

12 investors
InvestorType
NorwestVenture capital
S3 VenturesVenture capital
Innovation PartnershipsVenture capital
Gilde HealthcarePE / buyout
Panakes PartnersVenture capital
415 Capital—
Cordis—
Inventure Group—
M&L Group—
Michigan Biomedical Venture Fund—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Endovascular Engineering investors

12 investors are on record for Endovascular Engineering, including Norwest, S3 Ventures, Innovation Partnerships and Gilde Healthcare. By type, the record holds 4 venture capital firms and 1 private equity firm.

Free account
More of Endovascular Engineering with a free account
  • ·The complete investor list: 12 names
  • ·Watch Endovascular Engineering: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Endovascular Engineering. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View